-
Je něco špatně v tomto záznamu ?
Salt-kneading: alternative sizing of active pharmaceutical ingredients
M. Šimek, J. Vyňuchal, L. Tomášová,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- chlorid sodný chemie MeSH
- farmaceutická technologie metody MeSH
- léčivé přípravky chemie MeSH
- pomocné látky chemie MeSH
- rozpustnost MeSH
- velikost částic MeSH
- Publikační typ
- časopisecké články MeSH
The most of currently produced active pharmaceutical ingredients (APIs) are poorly soluble in the human body. One of the options how to increase their dissolution rate is reducing their particle size. If very small particles of API are desired, traditional milling methods often cause smeared, agglomerated or non-flowing particles due to the forces applied. We tried to compare some of milling methods with the salt-kneading method, which is not typically used in the pharmaceutical industry. Salt-kneading process is driven by several variable parameters (e.g. the amount, hardness and particle size of the salt-kneading material), which influence the degree of size reduction of API particles which are chafed by a surplus of salt-kneading material. A model poorly-soluble API was separately processed with oscillation mill, vibratory mill and kneader; and the morphology, size distribution and solid form of prepared particles were analyzed. Our basic variation of salt-kneading parameters showed the potential of the salt-kneading method, which appears a very effective method of API controlled reduction. The final size can be modified according to the amount and properties of the salt-kneading material. The availability of such a method equips pharmaceutical scientists with a size-reduction method that provides very small, rounded and free-flowing particles of the poorly soluble API and reduces non-preferred needle shape.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17014256
- 003
- CZ-PrNML
- 005
- 20170418105926.0
- 007
- ta
- 008
- 170413s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3109/10837450.2015.1086371 $2 doi
- 035 __
- $a (PubMed)26365246
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Šimek, Michal $u a Department of Solid State Chemistry , University of Chemistry and Technology Prague , Prague , Czech Republic. b Zentiva k.s. , Prague , Czech Republic.
- 245 10
- $a Salt-kneading: alternative sizing of active pharmaceutical ingredients / $c M. Šimek, J. Vyňuchal, L. Tomášová,
- 520 9_
- $a The most of currently produced active pharmaceutical ingredients (APIs) are poorly soluble in the human body. One of the options how to increase their dissolution rate is reducing their particle size. If very small particles of API are desired, traditional milling methods often cause smeared, agglomerated or non-flowing particles due to the forces applied. We tried to compare some of milling methods with the salt-kneading method, which is not typically used in the pharmaceutical industry. Salt-kneading process is driven by several variable parameters (e.g. the amount, hardness and particle size of the salt-kneading material), which influence the degree of size reduction of API particles which are chafed by a surplus of salt-kneading material. A model poorly-soluble API was separately processed with oscillation mill, vibratory mill and kneader; and the morphology, size distribution and solid form of prepared particles were analyzed. Our basic variation of salt-kneading parameters showed the potential of the salt-kneading method, which appears a very effective method of API controlled reduction. The final size can be modified according to the amount and properties of the salt-kneading material. The availability of such a method equips pharmaceutical scientists with a size-reduction method that provides very small, rounded and free-flowing particles of the poorly soluble API and reduces non-preferred needle shape.
- 650 _2
- $a pomocné látky $x chemie $7 D005079
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a léčivé přípravky $x chemie $7 D004364
- 650 _2
- $a chlorid sodný $x chemie $7 D012965
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a farmaceutická technologie $x metody $7 D013678
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vyňuchal, Jan $u c SBU Pigments and Dyes, Synthesia a.s. , Pardubice , Czech Republic. d Faculty of Chemical Technology , University of Pardubice , Pardubice , Czech Republic , and.
- 700 1_
- $a Tomášová, Lea $u e Tomášová Lea s.r.o., Pardubice-Bílé předměstí , Czech Republic.
- 773 0_
- $w MED00004889 $t Pharmaceutical development and technology $x 1097-9867 $g Roč. 21, č. 8 (2016), s. 972-979
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26365246 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170418110234 $b ABA008
- 999 __
- $a ok $b bmc $g 1200721 $s 975034
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 21 $c 8 $d 972-979 $e 20150912 $i 1097-9867 $m Pharmaceutical development and technology $n Pharm Dev Technol $x MED00004889
- LZP __
- $a Pubmed-20170413